Top Markets
Coin of the day
Immune Therapeutics, Inc. Immune Therapeutics, Inc.

Immune Therapeutics, Inc.

IMUN
Rank in Stocks #41154
Immune Therapeutics, Inc. currently conducts no significant business... Immune Therapeutics, Inc. currently conducts no significant business operations. Formerly known as TNI BioTech, Inc., the company adopted its present name in October 2014. Its corporate headquarters are situated in Orlando, Florida.
Share Price
$0.08
Last synced: 2023-11-13
Market Cap
$38.70K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Immune Therapeutics, Inc. (IMUN)

Category

Operating Margin for Immune Therapeutics, Inc. (IMUN)
Operating Margin as of 2026 TTM: 0.00%
According to Immune Therapeutics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Immune Therapeutics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.